Skip to main content

Table 3 Association of demographic, clinical, therapeutic parameters and PROs with health risk perception, stress and loneliness

From: Risk perception, well-being, depression and anxiety in children and adolescents with rheumatic diseases during the COVID-19 pandemic - results from the prospective multicenter KICK-COVID study in Germany

 

How dangerous…

How stressed…

How lonely…

beta

95% CI

p value

betaST

beta

95% CI

p value

betaST

beta

95% CI

p value

betaST

Female

0.20

-0.27; 0.66

0.403

0.03

0.13

-0.40; 0.66

0.625

0.02

0.66

0.22; 1.10

0.003

0.12

Age

-0.02

-0.13; 0.10

0.742

-0,01

0.09

-0.04; 0.22

0.174

0.06

0.00

-0.11; 0.10

0.935

0.01

JIA

(ref)

   

(ref)

   

(ref)

   

SLE

1.84

1.00; 2.68

< 0.001

0.18

0.49

-0.49; 1.46

0.328

0.04

0.02

-0.78; 0.82

0.953

0.01

JDM

0.37

-1.25; 2.00

0.651

0.02

0.02

-1.86; 1.91

0.980

0.01

-1.13

-2.68; 0.42

0.151

-0.06

PhGA

-0.14

-0.27; 0.00

0.054

-0.08

-0.03

-0.19; 0.13

0.732

-0.02

0.05

-0.08; 0.18

0.453

0.03

MTX

0.92

0.44; 1.40

< 0.001

0.16

0.45

-0.10; 1.00

0.109

0.07

0.16

-0.29; 0.61

0.498

0.03

bDMARD

0.54

0.06; 1.01

0.027

0.09

-0.16

-0.71; 0.39

0.567

-0.02

-0.10

-0.55; 0.35

0.651

-0.02

PGA

0.17

0.07; 0.27

0.001

0.15

0.22

0.11; 0.34

< 0.001

0.18

0.10

0.01; 0.19

0.045

0.09

CHAQ

0.85

0.30; 1.40

0.002

0.14

0.75

0.13; 1.38

0.019

0.11

1.04

0.52; 1.55

< 0.001

0.19

  1. betaST: standardized beta coefficient; JIA: Juvenile idiopathic arthritis; SLE: Systemic lupus erythematosus; JDM: Juvenile dermatomyositis; PhGA: Physician`s global assessment of disease activity; MTX: Methotrexate; bDMARD: Biologic disease modifying antirheumatic drug; PGA: Patient`s global assessment of health status; CHAQ: Child health assessment questionnaire